SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Thursday reported a loss of $11 million in its second quarter.
On a per-share basis, the Seattle-based company said it had a loss of 19 cents.
The biotechnology company posted revenue of $416,000 in the period.
In the final minutes of trading on Thursday, the company's shares hit 75 cents. A year ago, they were trading at $2.25.